How Does the Oncotype DX DCIS Score Revolutionize the Way DCIS Breast Cancer is Treated?
7 years ago
Genomic Health's Senior Director of Pathology, Dr. Rick Baehner, describes how the Oncotype DX DCIS Score is revolutionizing the way that DCIS breast cancer is being treated. Pathologists no longer have to rely on subjective assessments and can now examine individual breast cancer tumors to determine the aggressiveness.